<?xml version="1.0" encoding="UTF-8"?>
<p>Decriminalization of PWUD and access to harm reduction services for PWUD must also be prioritized during the COVID‐19 pandemic. Scholars have called for police and courts to immediately suspend arresting and sentencing people for low‐level crimes and misdemeanors [
 <xref rid="jia225551-bib-0019" ref-type="ref">19</xref>], which often include possession of drugs. Over 70 countries worldwide have introduced syringe exchange programmes [
 <xref rid="jia225551-bib-0020" ref-type="ref">20</xref>] and naloxone has saved tens of thousands of lives in the United States alone [
 <xref rid="jia225551-bib-0021" ref-type="ref">21</xref>]; however, access to these harm reduction services remains difficult in many countries. Anticipated scarcity of syringes and other injection equipment during the COVID‐19 pandemic may prompt PWUD to share syringes or experiment with new drugs or new drug use habits. To prevent outbreaks of HIV, HCV and other infectious diseases among PWUD, policy makers in nations with high rates of opioid use, including Russia and other Eastern European and Central Asian countries where new COVID‐19 cases are beginning to surge [
 <xref rid="jia225551-bib-0022" ref-type="ref">22</xref>], would be wise to consider implementing government‐supported programmes to purchase and allocate syringes. WHO‐endorsed naloxone distribution and training programmes should be re‐considered in contexts where harm reduction programmes are outlawed [
 <xref rid="jia225551-bib-0006" ref-type="ref">6</xref>].
</p>
